Correlates of second-line type 2 diabetes medication selection in the USA

OBJECTIVE: Past research provides insufficient evidence to inform second-line diabetes medication prescribing when metformin is no longer sufficient. We evaluated patient, prescriber, and health plan characteristics associated with selection of second-line diabetes medications in the USA. RESEARCH D...

Descripción completa

Detalles Bibliográficos
Autores principales: Ackermann, Ronald T, Wallia, Amisha, O'Brien, Matthew J, Kang, Raymond, Cooper, Andrew, Moran, Margaret R, Liss, David T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Epidemiology/Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706487/
https://www.ncbi.nlm.nih.gov/pubmed/29225892
http://dx.doi.org/10.1136/bmjdrc-2017-000421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706487/
https://www.ncbi.nlm.nih.gov/pubmed/29225892
http://dx.doi.org/10.1136/bmjdrc-2017-000421

Ejemplares similares